Lymphoma Clinical Trials in Cleveland
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +33 more
- Birmingham, Alabama
- +1423 more
2022-04-06
Apr 6, 2022B
Active, not recruiting
- B Cell Lymphoma
- Lymphoma
- Ixazomib
- +2 more
- Cleveland, Ohio
- +1 more
2022-03-03
Mar 3, 2022T
Recruiting
- Neoplasms
- +2 more
- La Jolla, California
- +7 more
2022-03-17
Mar 17, 2022C
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
- Birmingham, Alabama
- +42 more
2022-03-22
Mar 22, 2022E
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
- Greenbrae, California
- +226 more
2022-03-07
Mar 7, 2022B
Completed
- Lymphoma
- Acute Lymphoblastic Leukemia
- Apixaban
- No systemic anticoagulant prophylaxis
- Phoenix, Arizona
- +95 more
2022-02-10
Feb 10, 2022C
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Birmingham, Alabama
- +68 more
2022-03-03
Mar 3, 2022N
Active, not recruiting
- Glioma
- +49 more
- Pharmacological Study
- Romidepsin
- Duarte, California
- +11 more
2022-03-01
Mar 1, 2022B
Recruiting
- Acute Myeloid Leukemia
- +12 more
- Los Angeles, California
- +5 more
2022-02-15
Feb 15, 2022T
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
- Los Angeles, California
- +26 more
2022-02-14
Feb 14, 2022S
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- +19 more
- Intravenous (IV) SEA-CD40
- +4 more
- Birmingham, Alabama
- +18 more
2022-02-01
Feb 1, 2022T
Active, not recruiting
- Solid Tumor
- Lymphoma
- TTX-030
- +3 more
- Orange, California
- +15 more
2022-01-19
Jan 19, 2022S
Active, not recruiting
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
- Tucson, Arizona
- +422 more
2022-01-19
Jan 19, 2022S
Completed
- Lymphoma
- rituximab
- +7 more
- Anchorage, Alaska
- +47 more
2021-12-22
Dec 22, 2021E
Active, not recruiting
- Lymphoma
- +2 more
- rituximab
- +3 more
- Anchorage, Alaska
- +417 more
2021-12-29
Dec 29, 2021R
Active, not recruiting
- Chemotherapeutic Agent Toxicity
- +4 more
- Rituximab
- +5 more
- Birmingham, Alabama
- +44 more
2021-11-02
Nov 2, 2021C
Recruiting
- Stem Cell Transplant Complications
- +3 more
- physical therapy consult
- +8 more
- Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
2021-11-02
Nov 2, 2021M
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
- Birmingham, Alabama
- +38 more
2021-10-25
Oct 25, 2021S
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
- Anchorage, Alaska
- +258 more
2021-09-21
Sep 21, 2021R
Active, not recruiting
- Lymphoma
- Santa Monica, California
- +21 more
2021-09-20
Sep 20, 2021C
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
- Birmingham, Alabama
- +106 more
2021-09-02
Sep 2, 2021A
Active, not recruiting
- Leukemia
- Lymphoma
- rituximab
- +7 more
- Duarte, California
- +24 more
2021-08-16
Aug 16, 2021A
Completed
- Lymphoma
- Bleomycin Sulfate
- +11 more
- Tucson, Arizona
- +94 more
2021-06-10
Jun 10, 2021M
Completed
- Leukemia
- +2 more
- New York, New York
- +2 more
2021-03-01
Mar 1, 2021G
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
- Los Angeles, California
- +51 more
2021-01-07
Jan 7, 2021